Performance analysis of Zevra Therapeutics (ZVRA)
Annual Return
Over the past 3 years, ZVRA has had an average annual return of +29.65%, outperforming the benchmark SPY, which returned +22.45% annual.
Over the past 5 years, ZVRA has had an average annual return of -0.64%, underperforming the benchmark SPY, which returned +13.88% annual.
Over the past 10 years, ZVRA has had an average annual return of -20.77%, underperforming the benchmark SPY, which returned +15.44% annual.
Since Apr 16, 2015, ZVRA has had an average annual return of -22.18%, underperforming the benchmark SPY, which returned +14.02% annual.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| +22.40% | +7.53% | +27.05% | +42.97% | -47.33% | -22.24% | +84.91% | -78.73% | -56.06% | +37.28% | -85.15% | +77.32% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +0.40% | -0.80% | +4.42% | +9.23% | +13.91% | -5.41% | +22.40% | ||||||
| 2025 | -5.81% | +2.05% | -6.49% | -2.15% | +16.63% | +3.14% | +26.02% | -18.39% | +4.94% | +6.97% | -17.25% | +6.38% | +7.53% |
| 2024 | -11.75% | +16.41% | -13.83% | -20.99% | +1.17% | +5.41% | +32.60% | +17.96% | -9.37% | +17.57% | +14.51% | -10.75% | +27.05% |
| 2023 | +19.14% | +6.23% | -5.25% | -1.95% | -6.64% | +1.42% | -4.56% | +4.04% | -4.95% | -7.06% | +6.40% | +37.59% | +42.97% |
| 2022 | -17.28% | -17.66% | -15.11% | -11.39% | +3.61% | -3.49% | +25.70% | -2.56% | +14.10% | -10.06% | -15.02% | -3.76% | -47.33% |
| 2021 | -46.24% | +57.44% | -3.02% | +5.85% | +5.16% | +25.22% | -21.26% | -7.82% | +0.39% | +1.73% | -17.55% | +11.21% | -22.24% |
| 2020 | -2.66% | -17.63% | -25.83% | +33.33% | -37.31% | +52.38% | +44.92% | +75.74% | -22.70% | +0.99% | +77.21% | -30.71% | +84.91% |
| 2019 | +46.63% | -13.78% | -25.78% | -10.46% | +7.04% | +9.38% | -28.02% | -25.51% | -26.61% | -20.00% | -18.29% | -15.92% | -78.73% |
| 2018 | +54.31% | -6.40% | +35.06% | -34.82% | +20.40% | +4.84% | -36.92% | +26.82% | -7.69% | -54.99% | +18.51% | -30.49% | -56.06% |
| 2017 | +20.35% | +15.49% | +19.50% | -6.13% | -5.43% | -8.06% | -16.24% | -8.96% | +21.34% | +2.69% | +0% | +6.57% | +37.28% |
Drawdown analysis of Zevra Therapeutics (ZVRA)
The maximum drawdown for the ZVRA was -99.27%, occurring on May 22, 2020. This drawdown has not yet recovered.
The current ZVRA drawdown is -97.10%.
Since Apr 16, 2015 ZVRA has experienced the following drawdowns:
- 50% or more: 1 time
- 40% or more: 1 time
- 30% or more: 1 time
- 20% or more: 1 time
- 10% or more: 3 times
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -99.27% | Sep 18, 2015 | 1177 | May 22, 2020 | Ongoing | Ongoing | Ongoing |
| -19.68% | Jun 22, 2015 | 30 | Aug 4, 2015 | 8 | Aug 14, 2015 | 38 |
| -19.23% | Aug 17, 2015 | 5 | Aug 24, 2015 | 18 | Sep 18, 2015 | 23 |
| -8.72% | May 11, 2015 | 11 | May 27, 2015 | 3 | Jun 1, 2015 | 14 |
| -4.20% | Jun 18, 2015 | 1 | Jun 19, 2015 | 1 | Jun 22, 2015 | 2 |
| -2.86% | Jun 15, 2015 | 1 | Jun 16, 2015 | 1 | Jun 17, 2015 | 2 |
| -1.79% | Apr 16, 2015 | 7 | Apr 27, 2015 | 4 | May 1, 2015 | 11 |
| -0.97% | Jun 4, 2015 | 1 | Jun 5, 2015 | 1 | Jun 8, 2015 | 2 |
| -0.79% | May 1, 2015 | 1 | May 4, 2015 | 2 | May 6, 2015 | 3 |
| -0.61% | Jun 8, 2015 | 1 | Jun 9, 2015 | 1 | Jun 10, 2015 | 2 |
| -0.06% | Jun 10, 2015 | 1 | Jun 11, 2015 | 1 | Jun 12, 2015 | 2 |